ГОСТ Р ИСО 10993-7-2009; Страница 40

или поделиться

Ещё ГОСТы из 41757, используйте поиск в верху страницы

ГОСТ Р 43.0.3-2009 Информационное обеспечение техники и операторской деятельности. Ноон-технология в технической деятельности. Общие положения Informational ensuring of equipment and operational activity. Noon-technology in technical activity. General principles (Настоящий стандарт устанавливает общие положения, основные положения, относящиеся к информационным, интеллектуальным областям применения ноон-технологии в технической сфере, деятельности оператора. Стандарт может быть применен при разработке и использовании информационного обеспечения техники и операторской деятельности (ИОТОД), в том числе в виде информационного пространства виртуальной реальности, на основе единой ноон-технологии (ноон-технологии с расширенной технической поддержкой ее применения) ) ГОСТ Р 43.2.4-2009 Информационное обеспечение техники и операторской деятельности. Язык операторской деятельности. Cинтактика знаковых компонентов Informational ensuring of equipment and operational activity. Language of operation activity. Syntactics of sign’s components (Настоящий стандарт устанавливает общие положения по созданию знаковых компонентов (знаков) языка операторской деятельности (ЯзОД), положения по синтактике (синтактическому (структурному) представлению) знаковых компонентов (знаков) ЯзОД) ГОСТ Р 53594-2009 Продукция животноводства и корма. Иммуноферментный метод определения синтетических анаболических стимуляторов роста Livestock products and feedstuffs. Immunoenzyme method of determination of the synthetic growth promoters (Настоящий стандарт распространяется на корма, физиологические жидкости (моча), органы и ткани (мышцы, печень, глаза), а также шерсть животных и устанавливает иммуноферментный метод определения синтетических стимуляторов роста (метилтестостерона, 19-нортестостерона, дексаметазона, диэтилстильбестрола, тренболона, этинилэстрадиола и кленбутерола))

Страница 40

Страница 1

Untitled document

ГОСТ Р ИСО 10993-7— 2009

[34] HANDLOS, V. Determination of gas residuals in ethylene oxide sterilized materials — A literature survey. Archiv.

Pharm. Chemi. Sci. 4 1976: pp. 73 — 80

[35]HANDLOS. V. The hazards of ethylene oxide sterilization. Arch. Pharm. Chemi. Sci. 7 1979: pp. 939 — 949

[36] HARTMAN. P.A. and BOWMAN, P.B. Simple GLC determination of ethylene oxide and its reaction products in

drug and formulations. J. Pharm. Sci. 66(6) 1977: pp. 789 — 792

[37] Health Industry Manufacturers’ Association. Guidelines for the Analysis of Ethylene Oxide Residues in Medical

Devices (HIMA Document No. 1. Vof. 2). Washington. DC: HIMA. 1980

[38] HOLLINGSWORTH. R.. ROWE. V.. OYEN.F.. MCCALLISTER. D. and SPENCER. H. Toxicity of ethylene oxide

determined on experimental animals. AMA Arch. Ind. Health. 13 1956; pp. 217 — 227

[39] HUBAUX. A. and GILBERT, V. Decision and detection limits for linear calibration curves. Anal. Chem. 42{8) 1970;

pp. 849 — 855

[40] Improved detection and separation of glycols and ethylene oxide residues using GC. (Bulletin 789). Supelco. Inc.;

1980

[41] JACOBSON. K.. HACKLEY, E. and FEINSILVER. L. The toxicity of inhaled ethylene oxide and propylene oxide

vapors. AMA Arch. Ind. Health. 13 1956; pp. 237 — 244

[42]Japan Association of Disposable Medical Device Industries. Guideline for ethylene oxide sterilization of disposable

medical devices (second edition). Dec. 1989

[43]JOHNSON. M. Metabolism of chloroethanol in the rat. Biochem. Pharmacol. 16 1967a; pp. 185 — 199

[44]JOHNSON. M. Detoxication of ethylene chlorohydrin. Fd. Cosmet. Tox. 5 1967b; p. 499

[45]JONES-PRICE. C.. KIMMEL. T.. MARKES. T.. LEDOUX. T., REEL. J.. FISCHER. P.. LANGHOFF-PASCHKEL and

MARR. M. Teratologic Evaluation of Ethylene Oxide (CAS No. 75-78-8) in New Zealand White Rabbits (Final

report RB80-EO. NIEHS Contract No. I-ES-2127). Research Triangle Park. NC: National Institute of Environ

mental Health Sciences. 1982. (Cited in EPA. 1985)

[46]JONES-PRICE. C.. MARKS. T„ LEDOUX. T., REEL. J.. FISCHER. P.. LANGHOFF-PASCHKE. L.. MARR. M. and

KIMMEL. C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107-07-3) in New Zealand White Rabbits

(PB85-170959). Research Triangle Park. NC: National Institute of Environmental Health Sciences, 1985a

[47]JONES-PRICE. C.. MARKS. T.. LEDOUX. T.. REEL. J.. FISCHER. P.. LANGHOFF-PASCHKE. L.. MARR. M. and

KIMMEL. C. Teratologic Evaluation of Ethylene Chlorohydrin (CAS No. 107-07-3) in CD-1 тюе (PB85-172104).

Research Triangle Park. NC: National Institute of Environmental Health Sciences. 1985b

[48] KAREL. L.. LANDING. B. and HARVEY. T. The mtraperitoneal toxicity of some glycols, glycol ethers, glycol esters

and phthalates in mice. Fed. Proceedings. 6 1947; p. 342

[49] KASHTOCK. M. Use of specific retention volumes in evaluation of various types of columns for use in the trace

determination of ethylene glycol by gas chromatography. J. Chromatogr. 176 1979; pp. 25 — 35

[50] KAYE. M.M. and NEVELL. T.G. Statistical evaluation of methods using headspace gas chromatography for the

determination of ethylene oxide. Analyst. 110 1985; pp. 1067 — 1071

[51] KIKUCHI. H.. NAKAMURA. A. and TSUJI. K. Gas chromatographic determination with electron capture detection

of residual ethylene oxide in intraocular lenses. J. Assoc. Off. Anal. Chem. 71 1988: pp. 1057 — 1062

[52] KROES, R.. BOCK, B. and MARTIS. L. Ethylene oxide extraction and stability in water and blood. Personal

communication to the AAMI Committee. Jan 1985

[53] KULKARNI. R.K.. BARTAK. D.. OUSTERHOUT. D.K. and LEONARD. F. Determination of residual ethylene oxide

in catheters by gas-liquid chromatography. J. Biomed. Mat. Res. 2 1968: pp. 165 — 171

[54] LABORDE. J. and KIMMEL. C. The teratogenicity of ethylene oxide administered intravenously to mice. Tox. Appl.

Pharm. 56 1980: pp. 16 — 22

[55] LANDEN. W.O.. THOMPSON, D.W. and FLOYD. K.M. Determination of ethylene oxide and ethylene glycol in wet

surgical dressings. FDA By-Lines. No. 2. 1971

[56] LATVEN. A. and MOLITOR. H. Comparison of the toxic, hypnotic and irritating properties of eight organic solvents.

J. Pharm. Exp. Ther. 65 1939; pp. 89 — 94

[57] LAWRENCE. W., TURNER. J. and AUTIAN. J. Toxicity ofethylene chlorohydrin I; Acute toxicity studies. J. Pharm.

Sci. 60(4) 1971a; pp. 568 — 571

[58] LAWRENCE. W.. ITOH. K.. TURNER. J. and AUTIAN. J. Toxicity ofethylene chlorohydrin II: Subchronic toxicity and

special tests. J. Pharm. Sci. 60(8) 1971 b; pp. 1163 — 1168

[59] LAWRENCE. W.. DILLINGHAM. E.. TURNER. J. and AUTIAN. J. Toxicity profile of chloroacetaldehyde. J. Pharm.

Sci. 61(1) 1972: pp. 19 — 25

[60] LEE. H.T., DANIEL. A. and WALKER. C. Conformance test procedures (CTP) for verifying the labeling claims for

precision, bias, and interferences in in-vitro diagnostic devices used for the quantitative measurement of analytes

in human body fluids. In: Bureau of Medical Devices Biometrics Report 8202. Silver Spring. MD: Food and Drug

Administration. Apr. 1982

[61] LONG. G.L. and WINEFORDNER. J.D. Limit of detection— A closer look at the IUPAC definition. Anal. Chem.

55(7) 1983: pp. 712A— 724A

[62] LYNCH. D.. LEWIS. T.. MOORMAN. W.. SABHARWAL. P. and BURG. J. Toxic and mutagenic effects of ethylene

oxide and propylene oxide on spermatogenic functions in Cynomolgus monkeys. Toxicologist. 3:60